What is ALURW's health score?

ALLURION TECHNOLOGIES, INC. (ALURW) has a TradeApes health score of 36 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ALURW's estimated fair value?

Based on our 5-year discounted cash flow model, ALLURION TECHNOLOGIES, INC.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ALURW undervalued or overvalued?

Our model currently rates ALURW as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ALURW... Refresh in a moment for the full analysis.

ALLURION TECHNOLOGIES, INC. (ALURW)

Healthcare Inconclusive inconclusive weak

Updated: 2026-06-05

TradeApes Score

Financial Strength

40 Weak

Operating Trend

38 Weak

Relative Value

40 Weak

Capital Allocation

20 Stressed

Risk

35 Weak

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.